Ignacio Durán

17.3k citations
209 papers · 5.1k · 2 hit papers · h-index 37

Impact in

Papers in

    • Bladder and Urothelial Cancer Treatments 60
    • Urinary and Genital Oncology Studies 28
    • Renal cell carcinoma treatment 37
    • Prostate Cancer Treatment and Research 23

Ignacio Durán

201 papers receiving 5.0k citations

Ignacio Durán's Hit Papers

EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma 2023 · 92 citations
920+1+3Years since publication200400600

Peers

Ignacio Durán
Comparison fields: 5 of 114
  • Oncology 1.9k
  • Pulmonary and Respiratory Medicine 1.1k
  • Surgery 1.5k
  • Cancer Research 450
  • Neurology 352
Replace Lori A. Erickson with:
Lori A. Erickson United States
Alyssa M. Krasinskas United States
Lori J. Wirth United States
Maria Di Bartolomeo Italy
Jean‐Christophe Sabourin France
Tomoyuki Yokose Japan
Yoshiaki Inayama Japan
Shunji Takahashi Japan
John A. Chabot United States
Enrique Grande Spain
Ignacio Durán relative to Lori A. Erickson United States Lori A. Erickson's profile →
Citations per field
00.5×1.5×2.2×
Lori A. Erickson · 1×
Citations per year

Countries citing papers authored by Ignacio Durán

Since Specialization
Citations

This map shows the geographic impact of Ignacio Durán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Durán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Durán more than expected).

Fields of papers citing papers by Ignacio Durán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Durán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Durán. The network helps show where Ignacio Durán may publish in the future.

Co-authors

The 25 scholars most cited alongside Ignacio Durán, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ignacio Durán Line = papers co-authored together Ignacio Durán links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 209 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
Hit paper breakdown →
2021715
2 2006275
3 2017251
4 2014164
5 2017134
6 2017133
7 2006125
8 2015113
9 2008108
10 2019101
11
EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma
Hit paper breakdown →
202392
12 201188
13 202087
14 201486
15 200782
16 201280
17 201680
18 202178
19 201978
20 201077

About Ignacio Durán

Ignacio Durán is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Cancer Research, having authored 209 papers that have together received 5.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (60 papers), Renal cell carcinoma treatment (37 papers), Cancer Immunotherapy and Biomarkers (31 papers), Urinary and Genital Oncology Studies (28 papers), Prostate Cancer Treatment and Research (23 papers), Cancer Genomics and Diagnostics (16 papers), Neuroendocrine Tumor Research Advances (15 papers) and Lung Cancer Research Studies (12 papers). The work is most often cited by research in Oncology (1.9k citations), Pulmonary and Respiratory Medicine (1.1k citations), Surgery (1.5k citations), Cancer Research (450 citations) and Neurology (352 citations). Ignacio Durán has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Daniel Castellano, Yohann Loriot, Thomas Powles, Carmen Garrigós, Saman Maleki Vareki, Jonathan E. Rosenberg, Daniel P. Petrylak, Chunzhang Wu, Guru Sonpavde and Christof Vulsteke. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical & Translational Oncology, European Urology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact